Investor Relations

For press releases prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Theravance, Inc. Investor Relations Press Releases.


Press Releases
Date Title and Summary View
Apr 30, 2015 GEORGE TOWN, GRAND CAYMAN -- (Marketwired) -- 04/30/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today that Rick E Winningham, Chairman and Chief Executive Officer, is scheduled to present at the Bank of America Merrill Lynch 2015 Health Care Conference on Tuesday, May 12, 2015, at 3:00 p.m...
Apr 30, 2015 GEORGE TOWN, GRAND CAYMAN -- (Marketwired) -- 04/30/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial results for the period ended March 31, 2015 after market close on Thursday, May 7, 2015. An accompanying conference call will be held at 5:00 pm...
Apr 24, 2015 GEORGE TOWN, GRAND CAYMAN -- (Marketwired) -- 04/24/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced new positive data from studies of VIBATIV® (telavancin), the Company's FDA-approved antibiotic. These studies' results will be the focus of presentations at the 25th European Congres...
Apr 16, 2015 GEORGE TOWN, GRAND CAYMAN -- (Marketwired) -- 04/16/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that data from studies of VIBATIV® (telavancin), the Company's FDA-approved antibiotic, will be presented at the 25th European Congress of Clinical Microbiology and Infectious Diseas...
Apr 7, 2015 GEORGE TOWN, GRAND CAYMAN -- (Marketwired) -- 04/07/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that Rick E Winningham, Chairman and Chief Executive Officer, is scheduled to present at the 2015 Needham Healthcare Conference on Tuesday, April 14, 2015, at 8:00 a.m. EDT. The conference will be held from April 14-15 in New Yor...
Apr 2, 2015 GEORGE TOWN, GRAND CAYMAN -- (Marketwired) -- 04/02/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today that stock options to purchase an aggregate of 45,700 of the Company's ordinary shares were granted to six new non-executive officer employees on April 1, 2015. The options were granted i...
Mar 12, 2015 GEORGE TOWN, GRAND CAYMAN -- (Marketwired) -- 03/12/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced the initiation of a Phase 2b study of velusetrag (TD-5108), an investigational drug for the treatment of patients with gastroparesis and other gastrointestinal motility disorders. ...
Mar 10, 2015 GEORGE TOWN, GRAND CAYMAN -- (Marketwired) -- 03/10/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today reported financial results for the fourth quarter and year ending December 31, 2014. Revenue for the fourth quarter of 2014 was $1.4 million. Net loss for the fourth quarter of 2014 was $64.3 milli...
Mar 4, 2015 GEORGE TOWN, CAYMAN ISLANDS -- (Marketwired) -- 03/04/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) (the "Company") announced today that stock options to purchase an aggregate of 10,500 of the Company's ordinary shares were granted to three new non-executive officer employees on March 2, 2015. The options were granted in accordance with NASD...
Mar 3, 2015 GEORGE TOWN, GRAND CAYMAN -- (Marketwired) -- 03/03/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial results for the period ended December 31, 2014 after market close on Tuesday, March 10, 2015. An accompanying conference call will be held at 5:...
1
NextLast
Add to Briefcase = add release to Briefcase
By clicking on the link below, you will leave www.theravance.com.
CancelContinue
Form content here please :)